GPT and metabolic dysfunction-associated steatotic liver disease: In a recent study on non-obese NAFLD patients showing excess intake of dietary cholesterol, ezetimibe therapy decreased serum ALT levels and improved steatotic findings on ultrasonography in some patients [116].